Seqens Is A Global Leader In Developing And Producing Pharmaceutical Solutions And Specialty Ingredientsformerly Known As Novacap Groupthe Company Rebranded To Unify Its Operations Under A Single Nameseqens Focuses On Two Main Sectorspharmaceutical Synthesis And Specialty Ingredients In Pharmaceutical Synthesisseqens Specializes In Active Pharmaceutical Ingredientsapis Pharmaceutical Intermediatesand Custom Apisboasting A Portfolio Of Over 200 Apis And 500 Intermediatesin The Specialty Ingredients Sectorthe Company Produces Chemicals For Various Industriesincluding Cosmetics And Personal Careseqens Emphasizes Innovationutilizing Advanced Technologies Such As Custom Polymerslipidsand Biocatalysis With 24 Industrial Sites And 10 R&D Centers Across Three Continentsseqens Employs Around 3 200 Peoplethe Company Is Also Committed To High Standards Of Environmentalsocialand Governance Practiceshaving Received Ecovadis Platinum And Gold Certifications For Many Of Its Sitesgenerating Approximately A 1 1 Billion In Revenueseqens Is A Significant Player In Its Industryproviding High Quality Products And Services To A Diverse Customer Base
